The Global Equine Healthcare Market Size accounted for USD 2.5 Billion in 2022 and is projected to achieve a market size of USD 4.6 Billion by 2032 growing at a CAGR of 6.2% from 2023 to 2032.
Equine Healthcare Market Highlights
- Global Equine Healthcare Market revenue is expected to increase by USD 4.6 Billion by 2032, with a 6.2% CAGR from 2023 to 2032
- North America region led with more than 36% of equine healthcare market share in 2022
- Asia-Pacific Equine Healthcare Market growth will record a CAGR of around 6.8% from 2023 to 2032
- By indication, the parasite control segment has recorded more than 21% of the revenue share in 2022
- By technology, the pharmaceuticals segment has accounted more than 29% of the revenue share in 2022
- Increasing participation in equestrian sports and recreational riding, drives the Equine Healthcare Market value
Equine healthcare refers to the specialized medical care and maintenance provided to horses. This sector encompasses a wide range of services and products aimed at promoting the health, well-being, and performance of horses, including preventive care, diagnostics, treatment of illnesses and injuries, nutrition, dental care, and pharmaceuticals. Equine healthcare is critical for the equine industry, which includes activities such as horse racing, breeding, equestrian sports, and leisure riding. Healthy horses are not only valuable assets but also companions, making the healthcare market for these animals significant.
In recent years, the equine healthcare market has seen steady growth due to several factors. One key driver is the increasing awareness of the importance of horse health and welfare among horse owners, trainers, and breeders. Technological advancements in diagnostics and treatment options have also contributed to the expansion of the market. Moreover, the growth of equestrian sports and recreational riding has boosted the demand for equine healthcare products and services. As the equine industry continues to evolve, with a focus on performance improvement and the overall well-being of horses, the equine healthcare market is expected to experience continued growth, offering opportunities for innovation and investment in the coming years.
Global Equine Healthcare Market Trends
Market Drivers
- Increasing participation in equestrian sports and recreational riding
- Growing awareness of equine health and welfare
- Advancements in veterinary diagnostics and treatments
- Expanding global equine population
- Rising demand for specialized equine pharmaceuticals
Market Restraints
- High costs associated with equine healthcare
- Regulatory challenges in the approval of equine medications
Market Opportunities
- Adoption of digital health monitoring solutions for horses
- Expansion of telemedicine and telehealth services for equines
Equine Healthcare Market Report Coverage
Market |
Equine Healthcare Market
|
Equine Healthcare Market Size 2022 |
USD 2.5 Billion |
Equine Healthcare Market Forecast 2032 |
USD 4.6 Billion |
Equine Healthcare Market CAGR During 2023 - 2032 |
6.2% |
Equine Healthcare Market Analysis Period |
2020 - 2032 |
Equine Healthcare Market Base Year
|
2022 |
Equine Healthcare Market Forecast Data |
2023 - 2032 |
Segments Covered |
By Indication, By Product, By Distribution Channel, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Zoetis Inc., Merck & Co., Inc. (Animal Health Division), Boehringer Ingelheim Animal Health, Elanco Animal Health, IDEXX Laboratories, Inc., Dechra Pharmaceuticals PLC, CevaSantéAnimale, Vetoquinol S.A., Norbrook Laboratories Ltd., Neogen Corporation, Virbac Group, and Heska Corporation.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Equine Healthcare Market Dynamics
Horses, whether used for equestrian sports, leisure riding, agriculture, or other purposes, require a comprehensive range of healthcare services to ensure their optimal health, performance, and overall quality of life. Equine healthcare encompasses a broad spectrum of applications, including preventive care, diagnostic procedures, therapeutic interventions, and ongoing management of various health issues affecting horses. These applications extend to the development and distribution of pharmaceuticals, vaccines, supplements, and other products tailored specifically for equine health. Equine healthcare also encompasses nutritional guidance, exercise programs, and rehabilitation services for injured or ill horses.
The applications of equine healthcare are multifaceted. Preventive care, such as vaccinations, dental care, and routine check-ups, helps keep horses healthy and reduces the risk of diseases. Diagnostic procedures, including advanced imaging techniques like MRI and CT scans, aid in identifying and diagnosing various medical conditions and injuries in horses. Therapeutic interventions involve treatments, surgeries, and medications to address specific health issues or injuries. Additionally, equine healthcare supports the overall well-being of horses, which is critical for their performance, longevity, and the satisfaction of their owners and handlers. In essence, equine healthcare plays a vital role in ensuring the health, comfort, and longevity of these magnificent animals, whether they are companions, athletes, or work partners.
The equine healthcare market has exhibited consistent growth in recent years, driven by several key factors. One of the primary drivers is the increasing interest and participation in equestrian sports and recreational riding across the globe. As more individuals and organizations become involved in these activities, the demand for equine healthcare services, including veterinary care, diagnostics, and specialized treatments, has surged. This trend is further supported by a growing awareness of equine health and welfare, leading horse owners and enthusiasts to prioritize their animals' well-being. Advancements in veterinary medicine and technology have also played a pivotal role in the market's growth.
Equine Healthcare Market Segmentation
The global Equine Healthcare Market segmentation is based on indication, product, distribution channel, and geography.
Equine Healthcare Market By Indication
- Musculoskeletal Disorders
- Internal Medicine
- Parasite Control
- Equine Influenza
- Equine Herpes Virus
- West Nile Virus
- Tetanus
- Equine Encephalomyelitis
- Others
According to the equine healthcare industry analysis, the parasite control segment accounted for the largest market share in 2022. This growth can be attributed to several factors, including the recognition of the critical role that effective parasite management plays in maintaining the health and well-being of horses. Parasites, such as internal worms and external pests like ticks and flies, can have detrimental effects on equine health, leading to a range of issues, including weight loss, colic, and skin irritations. Consequently, horse owners and equine healthcare professionals have placed a strong emphasis on parasite control measures. Advancements in parasite control products and techniques have also driven growth in this segment. Pharmaceutical companies have developed more effective and safer anthelmintic drugs, allowing for more targeted and strategic deworming protocols.
Equine Healthcare Market By Product
- Vaccines
- Pharmaceuticals
- Anti-infectives
- Parasiticides
- Anti-inflammatory & Analgesics
- Other Pharmaceuticals
- Diagnostics
- Medicinal Feed Additives
- Software & Services
- Others
In terms of products, the pharmaceuticals segment is expected to witness significant growth in the coming years. One of the primary drivers is the increasing demand for specialized medications and therapies tailored specifically to the unique needs of horses. Horses, whether involved in racing, breeding, or recreational activities, require a range of pharmaceutical products for various health conditions, including pain management, respiratory issues, and musculoskeletal disorders. Moreover, advancements in veterinary pharmacology and drug formulation have led to more effective and safer equine medications. Pharmaceutical companies have introduced innovative drug delivery methods, such as long-acting formulations and targeted therapies, which not only enhance the treatment outcomes but also improve the convenience of administration for both horse owners and veterinarians. This has contributed to a higher level of trust and reliance on pharmaceuticals as a vital component of equine healthcare.
Equine Healthcare Market By Distribution Channel
- Veterinary Hospitals & Clinics
- E-commerce
- Others
According to the equine healthcare market forecast, the veterinary hospitals & clinics segment is expected to witness significant growth in the coming years. One of the key drivers behind this growth is the rising demand for specialized and advanced healthcare services for horses. Horse owners and professionals in the equine industry increasingly recognize the importance of regular check-ups, diagnostics, and specialized treatments to ensure the health and well-being of their equine companions. This has led to a higher volume of visits to veterinary hospitals and clinics dedicated to equine care. Additionally, advancements in veterinary medicine and technology have played a crucial role in the growth of this segment.
Equine Healthcare Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Equine Healthcare Market Regional Analysis
North America has emerged as a dominant region in the equine healthcare market in 2022. North America has a long history of horse ownership and equestrian sports, with a substantial equine population. The United States and Canada, in particular, have a robust and diverse equine industry that spans from racing and competition to recreational riding and breeding. This strong equine culture has naturally led to a significant demand for equine healthcare services and products. Moreover, North America benefits from a well-developed and advanced veterinary healthcare infrastructure. The region boasts a large number of specialized equine veterinary hospitals, clinics, and practitioners with expertise in horse care. These facilities are equipped with state-of-the-art diagnostic and treatment capabilities, ensuring high-quality care for horses. Additionally, the availability of well-trained veterinarians who can provide specialized care and advice is a crucial factor contributing to the region's dominance in the equine healthcare market.
Equine Healthcare Market Player
Some of the top equine healthcare market companies offered in the professional report include Zoetis Inc., Merck & Co., Inc. (Animal Health Division), Boehringer Ingelheim Animal Health, Elanco Animal Health, IDEXX Laboratories, Inc., Dechra Pharmaceuticals PLC, CevaSantéAnimale, Vetoquinol S.A., Norbrook Laboratories Ltd., Neogen Corporation, Virbac Group, and Heska Corporation.
CHAPTER 1. Industry Overview of Equine Healthcare Market
1.1. Definition and Scope
1.1.1. Definition of Equine Healthcare
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Equine Healthcare Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Equine Healthcare Market By Indication
1.2.3. Equine Healthcare Market By Product
1.2.4. Equine Healthcare Market By Distribution Channel
1.2.5. Equine Healthcare Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Equine Healthcare Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Equine Healthcare Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Equine Healthcare Market By Indication
5.1. Introduction
5.2. Equine Healthcare Revenue By Indication
5.2.1. Equine Healthcare Revenue (USD Billion) and Forecast, By Indication, 2020-2032
5.2.2. Musculoskeletal Disorders
5.2.2.1. Musculoskeletal Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Internal Medicine
5.2.3.1. Internal Medicine Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Parasite Control
5.2.4.1. Parasite Control Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Equine Influenza
5.2.5.1. Equine Influenza Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Equine Herpes Virus
5.2.6.1. Equine Herpes Virus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.7. West Nile Virus
5.2.7.1. West Nile Virus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.8. Tetanus
5.2.8.1. Tetanus Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.9. Equine Encephalomyelitis
5.2.9.1. Equine Encephalomyelitis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.10. Others
5.2.10.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Equine Healthcare Market By Product
6.1. Introduction
6.2. Equine Healthcare Revenue By Product
6.2.1. Equine Healthcare Revenue (USD Billion) and Forecast, By Product, 2020-2032
6.2.2. Vaccines
6.2.2.1. Vaccines Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Pharmaceuticals
6.2.3.1. Pharmaceuticals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.2. Anti-infectives
6.2.3.2.1. Anti-infectives Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.3. Parasiticides
6.2.3.3.1. Parasiticides Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.4. Anti-inflammatory & Analgesics
6.2.3.4.1. Anti-inflammatory & Analgesics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.5. Other Pharmaceuticals
6.2.3.5.1. Other Pharmaceuticals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Diagnostics
6.2.4.1. Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Medicinal Feed Additives
6.2.5.1. Medicinal Feed Additives Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Software & Services
6.2.6.1. Software & Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Others
6.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Equine Healthcare Market By Distribution Channel
7.1. Introduction
7.2. Equine Healthcare Revenue By Distribution Channel
7.2.1. Equine Healthcare Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
7.2.2. Veterinary Hospitals & Clinics
7.2.2.1. Veterinary Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. E-commerce
7.2.3.1. E-commerce Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Others
7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Equine Healthcare Market By Country
8.1. North America Equine Healthcare Market Overview
8.2. U.S.
8.2.1. U.S. Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.2.2. U.S. Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
8.2.3. U.S. Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.3. Canada
8.3.1. Canada Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
8.3.2. Canada Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3.3. Canada Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Equine Healthcare Market By Country
9.1. Europe Equine Healthcare Market Overview
9.2. U.K.
9.2.1. U.K. Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.2.2. U.K. Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.3. U.K. Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3. Germany
9.3.1. Germany Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.3.2. Germany Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.3. Germany Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.4. France
9.4.1. France Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.4.2. France Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
9.4.3. France Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.5. Spain
9.5.1. Spain Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.5.2. Spain Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
9.5.3. Spain Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.6.2. Rest of Europe Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
9.6.3. Rest of Europe Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Equine Healthcare Market By Country
10.1. Asia Pacific Equine Healthcare Market Overview
10.2. China
10.2.1. China Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.2.2. China Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.3. China Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3. Japan
10.3.1. Japan Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.3.2. Japan Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.3. Japan Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4. India
10.4.1. India Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.4.2. India Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.3. India Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5. Australia
10.5.1. Australia Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.5.2. Australia Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.3. Australia Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.6. South Korea
10.6.1. South Korea Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.6.2. South Korea Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.3. South Korea Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.7.2. Rest of Asia-Pacific Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
10.7.3. Rest of Asia-Pacific Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Equine Healthcare Market By Country
11.1. Latin America Equine Healthcare Market Overview
11.2. Brazil
11.2.1. Brazil Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.2.2. Brazil Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.3. Brazil Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3. Mexico
11.3.1. Mexico Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.3.2. Mexico Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.3. Mexico Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.4.2. Rest of Latin America Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.3. Rest of Latin America Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Equine Healthcare Market By Country
12.1. Middle East & Africa Equine Healthcare Market Overview
12.2. GCC
12.2.1. GCC Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.2.2. GCC Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.3. GCC Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.3. South Africa
12.3.1. South Africa Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.3.2. South Africa Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.3. South Africa Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Equine Healthcare Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.4.2. Rest of Middle East & Africa Equine Healthcare Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.3. Rest of Middle East & Africa Equine Healthcare Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Equine Healthcare Market
13.1. Equine Healthcare Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Equine Healthcare Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Zoetis Inc.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Zoetis Inc. 2022 Equine Healthcare Business Regional Distribution
14.1.4. Product/Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Merck & Co., Inc. (Animal Health Division)
14.3. Boehringer Ingelheim Animal Health
14.4. Elanco Animal Health
14.5. IDEXX Laboratories, Inc.
14.6. Dechra Pharmaceuticals PLC
14.7. CevaSantéAnimale
14.8. Vetoquinol S.A.
14.9. Norbrook Laboratories Ltd.
14.10. Neogen Corporation
14.11. Virbac Group
14.12. Heska Corporation